Stay updated on IMM60 and Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the IMM60 and Pembrolizumab Clinical Trial page.

Latest updates to the IMM60 and Pembrolizumab Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe record history shows Revision: v3.5.2 replacing Revision: v3.5.0.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedVersion 10 adds Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, IPDSharing, and Document Section to the record, and includes a QC note 'Quality Control Review Has Not Concluded' with a Returned entry dated 2026-03-24.SummaryDifference1%

- Check39 days agoChange DetectedRevision: v3.5.0 was added and revision: v3.4.3 was removed from the history.SummaryDifference0.1%

- Check46 days agoChange DetectedAdded a 'Results Submitted' entry in the Record History and updated the version to v3.4.3. The previous 'No Results Posted' entry was removed.SummaryDifference0.2%

- Check74 days agoChange DetectedA new revision tag 'Revision: v3.4.2' is added to the history, and the page removes a funding-notice about government operations as well as the earlier 'Revision: v3.4.1' entry. These are minor version-tracking updates and do not alter study data or core page content.SummaryDifference0.8%

- Check81 days agoChange DetectedNotice about government funding and operating status added; revision history updated to v3.4.1 (from v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

Stay in the know with updates to IMM60 and Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMM60 and Pembrolizumab Clinical Trial page.